PFSA.US Profusa, Inc. Common Stock

Healthcare Health Care Technology USA Stocks
0.4480 USD
Close of Nov 15, 2026
0.4005 378.75
Market cap
USD 271K
P/E
0.0x
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is PFSA.US undervalued?

Graham number

The Graham number of Profusa, Inc. Common Stock cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Profusa, Inc. Common Stock fundamental analysis

No fundamental analysis for Profusa, Inc. Common Stock yet.

Profusa, Inc. Common Stock stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Profusa, Inc. Common Stock

Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, …

Full company profile